GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SKAN Group AG (LTS:0SKN) » Definitions » Additional Paid-In Capital

SKAN Group AG (LTS:0SKN) Additional Paid-In Capital : CHF0.0 Mil(As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is SKAN Group AG Additional Paid-In Capital?



SKAN Group AG Additional Paid-In Capital Historical Data

The historical data trend for SKAN Group AG's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SKAN Group AG Additional Paid-In Capital Chart

SKAN Group AG Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
- - - -

SKAN Group AG Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Additional Paid-In Capital Get a 7-Day Free Trial - - - - -

SKAN Group AG Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

SKAN Group AG Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of SKAN Group AG's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


SKAN Group AG Business Description

Traded in Other Exchanges
Address
Kreuzstrasse 5, Allschwil, CHE, 4123
SKAN Group AG is a global market and technological company for isolators, cleanroom devices, and decontamination processes for the aseptic production of biopharmaceutical substances. Its core competency is the design and development of process isolators for the aseptic filling of biopharmaceutical products. The company offer its customers process support, services, and consumables. Its products include biological indicators, isolators, Laboratory/cleanroom equipment, laminar flow, safety workbench, and transfer system.

SKAN Group AG Headlines

No Headlines